Physician profile
Alina Jaffer
NPI 1700591724
$1,229.98
in general payments reported to CMS, 2019-2025
7 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $75.28 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $969 · Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $969.20 |
| Food and Beverage | $260.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,046.12 | 2025 | General - Therapies |
| Bioventus LLC | $67.28 | 2024-2025 | Durolane, Xcell, Exogen Ultrasound Bone Healing System |
| Sanara Medtech INC. | $26.75 | 2025 | Biasurge |
| Solventum Corporation | $25.24 | 2025 | V.A.C. Veraflo, Prevena |
| Highridge Medical LLC | $23.02 | 2024 | Ebi Osteogen Implantable Bone Growth Stimulator, Biomet Ebi Bone Healing System, Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Pacira Pharmaceuticals Incorporated | $21.55 | 2025 | Exparel |
| Lightbody Medical Technologies INC | $20.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alina Jaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.